Xerostomia Secondary to Sjögren’s Syndrome in the Elderly: Recognition and Management

ISSN： 1170-229X

Source： Drugs & Aging, Vol.22, Iss.11, 2005-01, pp. : 887-899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sjögren's Syndrome: Diagnosis and Therapeutic Challenges in the Elderly

By Ng Kristine P. Isenberg David A.

Drugs & Aging, Vol. 25, Iss. 1, 2008-01 ,pp. : 19-33

Adis International

Access to resources Recommend Favorite

Review of the Pharmacological Properties and Clinical Usefulness of Muscarinic Agonists for Xerostomia in Patients with Sjögren's Syndrome

By Yasuda H. Niki H.

Clinical Drug Investigation, Vol. 22, Iss. 2, 2002-01 ,pp. : 67-73

Adis International

Access to resources Recommend Favorite

Myelopathy in Sjögren's Syndrome: Role of Nonsteroidal Immunosuppressants

By Rogers S.J. Williams C.S. Román G.C.

Drugs, Vol. 64, Iss. 2, 2004-01 ,pp. : 123-132

Adis International

Access to resources Recommend Favorite

Lamotrigine: Sjögren's syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1271, 2009-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Rituximab shows potential in patients with primary Sjögren's syndrome

Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite